PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Rifampicin
Presentation Product Chemical substance Chapter Items dispensed
Rifampicin 300mg capsules
0501090R0AAABAB
Rifampicin Rifampicin Infections 2,424
Rifampicin 150mg capsules
0501090R0AAAAAA
Rifampicin Rifampicin Infections 909
Rifadin 300mg capsules
0501090R0BBABAB
Rifadin Rifampicin Infections 813
Rifadin 150mg capsules
0501090R0BBAAAA
Rifadin Rifampicin Infections 263
Rifampicin 100mg/5ml oral suspension
0501090R0AAAFAF
Rifampicin Rifampicin Infections 253
Rifadin 100mg/5ml syrup
0501090R0BBACAF
Rifadin Rifampicin Infections 17
Rimactane 300mg capsules
0501090R0BCABAB
Rimactane Rifampicin Infections 1
Rifadin 600mg inf vials
0501090R0BBAEAD
Rifadin Rifampicin Infections No data available
Rifampicin 120mg/5ml oral liquid
0501090R0AAAMAM
Rifampicin Rifampicin Infections No data available
Rifampicin 150mg/5ml oral liquid
0501090R0AAAKAK
Rifampicin Rifampicin Infections No data available
Rifampicin 200mg/5ml oral liquid
0501090R0AAANAN
Rifampicin Rifampicin Infections No data available
Rifampicin 210mg/5ml oral liquid
0501090R0AAAUAU
Rifampicin Rifampicin Infections No data available
Rifampicin 30.5mg/5ml oral liquid
0501090R0AAAQAQ
Rifampicin Rifampicin Infections No data available
Rifampicin 300mg/5ml oral liquid
0501090R0AAAPAP
Rifampicin Rifampicin Infections No data available
Rifampicin 480mg/5ml oral liquid
0501090R0AAARAR
Rifampicin Rifampicin Infections No data available
Rifampicin 600mg inf vials
0501090R0AAADAD
Rifampicin Rifampicin Infections No data available
Rimactane 100mg/5ml syrup
0501090R0BCACAF
Rimactane Rifampicin Infections No data available
Rimactane 150mg capsules
0501090R0BCAAAA
Rimactane Rifampicin Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.